Investing
CapEx
Vertex Pharmaceuticals CapEx decreased by 10.7% to $133.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 227.8%, from $40.70M to $133.40M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 16.8% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
Detailed definition
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Peer comparison
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
Metric ID:
capital_expendituresHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $49.90M | $52.40M | $61.80M | $63.60M | $53.30M | $54.20M | $33.60M | $42.10M | $59.60M | $40.60M | $58.10M | $68.40M | $69.00M | $67.70M | $92.60M | $40.70M | $145.70M | $101.80M | $149.40M | $133.40M |
| QoQ Change | — | +5.0% | +17.9% | +2.9% | -16.2% | +1.7% | -38.0% | +25.3% | +41.6% | -31.9% | +43.1% | +17.7% | +0.9% | -1.9% | +36.8% | -56.0% | +258.0% | -30.1% | +46.8% | -10.7% |
| YoY Change | — | — | — | — | +6.8% | +3.4% | -45.6% | -33.8% | +11.8% | -25.1% | +72.9% | +62.5% | +15.8% | +66.7% | +59.4% | -40.5% | +111.2% | +50.4% | +61.3% | +227.8% |
Range$33.60M – $149.40M
CAGR+23.0%
Avg YoY Growth+37.8%
Median YoY Growth+33.1%
CapEx at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's capex?
- Vertex Pharmaceuticals (VRTX) reported capex of $133.40M in Q1 2026.
- How has Vertex Pharmaceuticals's capex changed year-over-year?
- Vertex Pharmaceuticals's capex increased by 227.8% year-over-year, from $40.70M to $133.40M.
- What is the long-term trend for Vertex Pharmaceuticals's capex?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's capex has grown at a 16.8% compound annual growth rate (CAGR), from $235.00M to $437.60M.
- What does capex mean?
- Cash spent on purchasing or maintaining physical assets like machinery and facilities.